Design and synthesis of fluoroquinophenoxazines that interact with human telomeric g-quadruplexes and their biological effects

Wenhu Duan, Anupama Rangan, Hariprasad Vankayalapati, Mu Yong Kim, Qingping Zeng, Daekyu Sun, Haiyong Han, Oleg Yu Fedoroff, David Nishioka, Sun Young Rha, Elzbieta Izbicka, Daniel D. Von Hoff, Laurence H. Hurley

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

In this study we have identified a new structural motif for a ligand with G-quadruplex interaction that results in biological effects associated with G-quadruplex-interactive compounds. Fluoroquinolones have been reported to possess weak telomerase inhibitory activity in addition to their better known bacterial gyrase poisoning. Starting with a fluoroquinobenzoxazine, which has modest potency in a human topoisomerase II assay, we have designed a more potent inhibitor of telomerase that has lost its topoisomerase II poisoning activity. This fluoroquinophenoxazine (FQP) interacts with G-quadruplex structures to inhibit the progression of Taq polymerase in a G-quadruplex polymerase stop assay. In addition, we demonstrate by 1H NMR studies that this compound interacts with telomeric G-quadruplex structures by external stacking to the G-tetrad with both the unimolecular fold-over and the parallel G-quadruplex structures. A photocleavage assay confirms the FQP interaction site, which is located off center of the external tetrad but within the loop region. Molecular modeling using simulated annealing was performed on the FQP-parallel G-quadruplex complex to determine the optimum FQP orientation and key molecular interactions with the telomeric G-quadruplex structure. On the basis of the results of these studies, two additional FQP analogues were synthesized, which were designed to test the importance of these key interactions. These analogues were evaluated in the Taq polymerase stop assay for G-quadruplex interaction. The data from this study and the biological evaluation of these three FQPs, using cytotoxicity and a sea urchin embryo system, were in accord with the predicted more potent telomeric G-quadruplex interactions of the initial lead compound and one of the analogues. On the basis of these structural and biological studies, the design of more potent and selective telomeric G-quadruplex-interactive compounds can be envisaged.

Original languageEnglish
Pages (from-to)103-120
Number of pages18
JournalMolecular Cancer Therapeutics
Volume1
Issue number2
Publication statusPublished - 2001 Dec

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Design and synthesis of fluoroquinophenoxazines that interact with human telomeric g-quadruplexes and their biological effects'. Together they form a unique fingerprint.

  • Cite this

    Duan, W., Rangan, A., Vankayalapati, H., Kim, M. Y., Zeng, Q., Sun, D., Han, H., Fedoroff, O. Y., Nishioka, D., Rha, S. Y., Izbicka, E., Von Hoff, D. D., & Hurley, L. H. (2001). Design and synthesis of fluoroquinophenoxazines that interact with human telomeric g-quadruplexes and their biological effects. Molecular Cancer Therapeutics, 1(2), 103-120.